InMode Seeks To Expand Beyond Plastic Surgery, Aiming For New Heights

Trending News ☀️

INMODE ($NASDAQ:INMD): InMode Ltd is an Israeli medical technology company that has grown rapidly in the past few years. The company seeks to continually expand their reach beyond the traditional realm of plastic surgery and pursue new heights of success. InMode’s breakthrough technology has already revolutionized how plastic surgery can be approached, providing doctors and patients with a much more effective and less invasive approach to cosmetic procedures. If they are able to break into the industry, there is no limit to what they can achieve. Already, the company has made strides in various medical fields such as dermatology, cosmetics, and ENT.

With their innovative technology, InMode is in a prime position to continue innovating and pushing the boundaries of what is possible in the medical world. With their cutting-edge technology and expansive vision, they have the potential to revolutionize the medical industry in ways never before seen. As they continue to expand and explore new opportunities, there is no telling what the future holds for InMode Ltd.

Stock Price

InMode LTD has been focused on offering services in plastic surgery, but is now seeking to expand beyond this sector. On Thursday, the company’s stock opened at $31.7 and closed at $31.5, up by 0.6% from its last closing price of 31.3. This suggests that investors are confident in InMode’s ability to reach new heights in its expansion plans. As part of its plans to expand its offerings, InMode plans to focus on improving technological advancements and providing specialized treatments to meet the needs of their customers.

The company also seeks to expand its reach globally, aiming to become a leader in the medical aesthetics industry. With its experienced team of professionals and innovative approach to service, InMode is well-positioned to achieve success in its expansion efforts. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Inmode Ltd. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Inmode Ltd. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Inmode Ltd. More…

Key Ratios Snapshot

Some of the financial key ratios for Inmode Ltd are shown below. More…

Analysis

At GoodWhale, we examine financials to provide investors insights into potential investments. After conducting an analysis of INMODE LTD, we determined that INMODE LTD has a high health score of 10/10 with regard to its cashflows and debt, meaning the company is capable of paying off debt and funding future operations. We classified INMODE LTD as a ‘Gorilla’, a type of company that has achieved stable and high revenue or earning growth due to its strong competitive advantage. This makes INMODE LTD a potentially attractive target to investors looking for companies with strong asset and growth profiles, as well as good profitability. However, with regards to dividends, INMODE LTD may be considered weak in comparison to other companies in their industry. More…

Peers

The market for aesthetic medical device is highly competitive with InMode Ltd. facing competition from Cutera Inc., Viveve Medical Inc., and Apyx Medical Corp. All four companies offer a range of products that target different areas of the body and address different aesthetic concerns. InMode Ltd. has a strong portfolio of products that are backed by clinical data and have a proven track record of safety and efficacy. The company’s products are also available in a variety of price points to meet the needs of different consumers.

– Cutera Inc ($NASDAQ:CUTR)

Cutera Inc is a medical device company that provides aesthetic treatments to patients worldwide. Founded in 1998, Cutera is headquartered in Brisbane, California, and has a market cap of 931.59M as of 2022. The company’s Return on Equity is -111.73%. Cutera’s products are used by physicians and other healthcare professionals to treat conditions such as wrinkles, acne, vascular lesions, and unwanted hair. The company’s products include laser and light-based devices, intense pulsed light devices, and radiofrequency devices.

– Viveve Medical Inc ($NASDAQ:VIVE)

Viveve Medical Inc. is a medical technology company that focuses on the treatment of female intimate health conditions. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity, the condition where the vaginal walls become stretched and loose. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

Viveve Medical Inc has a market cap of 6.19M as of 2022. The company’s Return on Equity is -179.17%. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

– Apyx Medical Corp ($NASDAQ:APYX)

Apyx Medical Corp is a medical device company that develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Apyx Medical Corp has a market cap of 149.01M as of 2022, a Return on Equity of -22.62%. The company develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Summary

INMODE LTD is an Israeli company that specializes in medical technologies for aesthetic procedures. They have developed a platform for combining radio frequency and optical energy to deliver non-invasive treatments. Their products are designed to reduce pain and speed up recovery. Analysts have observed positive trends in INMODE’s stock performance, as well as increased customer demand for their technologies.

The company’s strategy of constantly innovating and striving for excellence has been seen as one of the main drivers of their success. Investors can expect to see strong revenue growth, and a potential long-term return on their investments.